Delivery Order SPE2DB20D3505-SPE2DB25FU6B2
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,637.97 Firm Fixed Price Delivery Order is for the supply of 90-count bottles of 300 mg Irbesartan tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $37,807.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of Irbesartan 300 mg tablets for a period ending on March 24, 2025. The contract is a Firm Fixed Price (FFP) arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,202.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg Tablets in 90-count packages, with a completion date of April 28, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, SPE2DB22D3016|SPE2DB25FAUL2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,702.83 firm fixed-price delivery order is for the supply of 4,568,000 units of the medication Irbesartan 150 mg tablets. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.84 firm fixed-price delivery order contract is for the supply of Irbesartan 300 mg tablets. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,432.74, is for the delivery of Irbesartan 300 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Irbesartan 150 mg tablets. The fixed-price delivery order, valued at $3,303.32, has a period of performance through February 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
This federal contract award, SPE2DB20D3104|SPE2DB24FV8C6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,348.70 firm fixed-price delivery order is for the provision of 4565111628 - Irbesartan 150 mg Tablets in 90-count packages, with a performance period ending on July 11, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,223.37 firm fixed price delivery order is for the supply of 4,564,960,650 Irbesartan 150 mg tablets in quantities of 90. The award has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,564.06, is for the provision of Irbesartan 300 mg tablets to support federal healthcare programs. It is a Firm Fixed Price contract with a completion date of February 11, 2025. The contract is not designated with a specific set-aside requirement, indicating open competition....